Europe’s pharmaceutical industry has warned the conflict in Ukraine is disrupting supplies of medicines and clinical trials, while pledging free medicines to the humanitarian effort to those caught in or fleeing from the Russian invasion. A representative of the European Federation of Pharmaceutical Industries and Associations, which has an affiliate in Ukraine, told BioWorld that the disruption has left pharma industry staff in that country taking to emergency shelters.